Edap TMS SA (EDAP)
7.11
+0.04
(+0.57%)
USD |
NASDAQ |
May 10, 10:42
Edap TMS Cash from Investing (TTM): -4.703M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -4.703M |
September 30, 2023 | 13.57M |
June 30, 2023 | -4.131M |
March 31, 2023 | -3.363M |
December 31, 2022 | -2.508M |
Date | Value |
---|---|
September 30, 2022 | -20.66M |
June 30, 2022 | -2.432M |
March 31, 2022 | -2.360M |
December 31, 2021 | -1.938M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-20.66M
Minimum
Sep 2022
13.57M
Maximum
Sep 2023
-3.170M
Average
-2.508M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
Biophytis SA | 0.3879M |
DBV Technologies SA | -0.808M |
Cellectis SA | -15.51M |
Genfit SA | -- |
Biodexa Pharmaceuticals Plc | -0.3289M |